Drug Profile
Pilocarpine - Controlled Therapeutics
Alternative Names: Pilobuc; Pilocarpine controlled release insert - Controlled TherapeuticsLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Controlled Therapeutics (Scotland)
- Developer Controlled Therapeutics (Scotland); Marillion Pharmaceuticals
- Class Alkaloids; Antiglaucomas; Eye disorder therapies; Furans; Imidazoles; Ketones; Miotics; Small molecules
- Mechanism of Action Muscarinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Xerostomia
Most Recent Events
- 19 Jun 2015 Discontinued - Phase-II for Xerostomia in United Kingdom (Buccal)
- 01 Jun 2010 Pilocarpine buccal insert is still in phase II development for Xerostomia
- 27 Feb 2008 Controlled Therapeutics' pilocarpine buccal insert licensed to Marillion Pharmaceuticals worldwide for the treatment of xerostomia